Progress on the hepatotoxicity of lipid-lowering drugs and its prevention strategies / 药学实践杂志
Journal of Pharmaceutical Practice
; (6): 412-415,464, 2014.
Article
de Zh
| WPRIM
| ID: wpr-790376
Bibliothèque responsable:
WPRO
ABSTRACT
Hepatotoxicity is one of the most common adverse reactions during anti -hyperlipidemia treatment .Mechanisms of anti-hyperlipidemia drug-induced hepatotoxicity are not clear yet , but most of the toxic reactions are dose-related hypersensitivity and could be released after drug withdrawal .It is accepted that clinical risk factors for the development of hepatotoxicity during anti -hyper-lipidemia treatment are high age and chronic illnesses .Treatment of anti-hyperlipidemia drug-induced hepatotoxicity has not been uni-fied and most of the treatments are non-specific and symptomatic .Researching hypotoxicity and hepatoprotection antihyperlipidemia drug, especially TCM and pharmaceutics will become a promising direction .
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Journal of Pharmaceutical Practice
Année:
2014
Type:
Article